Pasithea reports tumor reductions in neurofibromatosis trial
We haven't written up this one. Investing.com has the full story — the link below goes straight to it.
More in Health & Medicine
Africa: All of Africa Today - November 13, 2026
[allAfrica]
Japan’s second bird flu case this season confirmed in Chiba
The prefecture will cull about 40,000 egg-laying chickens at a farm in Asahi.
'Soju should not exist': Surgeon warns of addiction risk from cheap, strong alcohol
com. A practicing surgeon has issued a strong warning about the dangers of soju — a popular traditional Korean alcohol that is now mass manufactured — drawing on his own experience of severe alcohol…
Experimental GLP-1 drug demonstrates pain relief in people with osteoarthritis during trials
A pooled analysis of the studies found that about two-thirds of participants receiving the drug retatrutide experienced at least a 50% reduction in knee pain, compared with 38% of those receiving a…
Pharma: Bayer receives green light for stroke medication
For the pharmaceutical division, US approval is crucial: its bestseller Xarelto is losing sales. Asundexian is intended to fill the gap - especially in the US, where Bayer is growing the fastest.
